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The analysis of extractable and leachable compounds from medical grade plastics is a complex issue that is 
compounded by the presence of many chemical species that are either direct or indirect reaction and/or 
degradation products of additives, process aids and polymer agents. These compounds may be present at 
various levels and the potential for adverse effects on cell growth remains to be determined and warrants further 
investigation. Since many of these films undergo aggressive processing steps, such as, thermal extrusion and 
gamma irradiation there is the potential for many unknown degradation products to be formed at each step of 
the processing. In addition, the absolute identification of many of these chemical compounds remains unknown. 
Within the various applications of single-use disposable bioprocessing, the presence of bis di-tert butyl phenyl 
phosphate (bDtBPP), a common gamma irradiation degradation product of tris (2,4-ditert-butylphenyl) phosphite 
(TBPP), has been shown to have a profoundly negative impact on cell growth for certain lines.  The presence of 
bDtBPP even at low levels (on the order of 10ppb) has been shown to inhibit cell growth performance 
percentages in some lines by as much as 30-50% [1]. 
 
The quantitative analysis of this compound becomes increasingly difficult at lower levels due to either; 1) 
irreversible binding of strongly charged phosphate groups to glassware and other labware used in processing 
samples, or 2) hydrolytic degradation in aqueous solutions, or 3) any combination of the two.  Losses from either 
of these conditions has been show to give rise to variations in quantitative analysis results as high as 50% when 
testing ranges are set between 5-100 parts per billion (ppb) in water. To this end, we have investigated the fate 
of this compound at part per billion levels to gain insight into possible mechanisms associated the variations 
observed.  The hydrolytic degradation as well as irreversible binding to various substrates such as HPLC vials, 
pipette tips, etc. has been investigated extensively. We propose mitigation strategies which allow for low level 
quantitative analysis of this compound to achieve a coefficient of variation (CV) within the range of 10-20%, for 
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